126 related articles for article (PubMed ID: 9184782)
1. Folic acid supplementation and cell kinetics of rectal mucosa in patients with ulcerative colitis.
Biasco G; Zannoni U; Paganelli GM; Santucci R; Gionchetti P; Rivolta G; Miniero R; Pironi L; Calabrese C; Di Febo G; Miglioli M
Cancer Epidemiol Biomarkers Prev; 1997 Jun; 6(6):469-71. PubMed ID: 9184782
[TBL] [Abstract][Full Text] [Related]
2. Calcium and colorectal epithelial cell proliferation in ulcerative colitis.
Bostick RM; Boldt M; Darif M; Wood JR; Overn P; Potter JD
Cancer Epidemiol Biomarkers Prev; 1997 Dec; 6(12):1021-7. PubMed ID: 9419397
[TBL] [Abstract][Full Text] [Related]
3. Rectal cell proliferation and colon cancer risk in ulcerative colitis.
Biasco G; Paganelli GM; Miglioli M; Brillanti S; Di Febo G; Gizzi G; Ponz de Leon M; Campieri M; Barbara L
Cancer Res; 1990 Feb; 50(4):1156-9. PubMed ID: 2297764
[TBL] [Abstract][Full Text] [Related]
4. Differential activation of total and EGF receptor (EGF-R) tyrosine kinase (tyr-k) in the rectal mucosa in patients with adenomatous polyps, ulcerative colitis and colon cancer.
Malecka-Panas E; Kordek R; Biernat W; Tureaud J; Liberski PP; Majumdar AP
Hepatogastroenterology; 1997; 44(14):435-40. PubMed ID: 9164515
[TBL] [Abstract][Full Text] [Related]
5. Proliferative and antigenic properties of rectal cells in patients with chronic ulcerative colitis.
Biasco G; Lipkin M; Minarini A; Higgins P; Miglioli M; Barbara L
Cancer Res; 1984 Nov; 44(11):5450-4. PubMed ID: 6488197
[TBL] [Abstract][Full Text] [Related]
6. Endoscopic and histological patchiness in treated ulcerative colitis.
Kim B; Barnett JL; Kleer CG; Appelman HD
Am J Gastroenterol; 1999 Nov; 94(11):3258-62. PubMed ID: 10566726
[TBL] [Abstract][Full Text] [Related]
7. Rectal mucosal proliferation and risk of colorectal adenomas: results from a randomized controlled trial.
Sandler RS; Baron JA; Tosteson TD; Mandel JS; Haile RW
Cancer Epidemiol Biomarkers Prev; 2000 Jul; 9(7):653-6. PubMed ID: 10919733
[TBL] [Abstract][Full Text] [Related]
8. Circadian variations of rectal cell proliferation in patients affected by advanced colorectal cancer.
Brandi G; Calabrese C; Pantaleo MA; Morselli Labate A; Di Febo G; Hakim R; De Vivo A; Di Marco MC; Biasco G
Cancer Lett; 2004 May; 208(2):193-6. PubMed ID: 15142678
[TBL] [Abstract][Full Text] [Related]
9. [Risk factors for ulcerative colitis associated colorectal cancers in a Hungarian cohort of ulcerative colitis patients].
Lakatos L; Mester G; Erdélyi Z; David G; Pandúr T; Balogh M; Fischer S; Vargha P; Lakatos PL
Orv Hetil; 2006 Jan; 147(4):175-81. PubMed ID: 16515026
[TBL] [Abstract][Full Text] [Related]
10. Enhanced epithelial cell turnover associated with p53 accumulation and high p21WAF1/CIP1 expression in ulcerative colitis.
Arai N; Mitomi H; Ohtani Y; Igarashi M; Kakita A; Okayasu I
Mod Pathol; 1999 Jun; 12(6):604-11. PubMed ID: 10392637
[TBL] [Abstract][Full Text] [Related]
11. Methodological findings and considerations in measuring colorectal epithelial cell proliferation in humans.
Bostick RM; Fosdick L; Lillemoe TJ; Overn P; Wood JR; Grambsch P; Elmer P; Potter JD
Cancer Epidemiol Biomarkers Prev; 1997 Nov; 6(11):931-42. PubMed ID: 9367067
[TBL] [Abstract][Full Text] [Related]
12. Colorectal epithelial cell proliferative kinetics and risk factors for colon cancer in sporadic adenoma patients.
Bostick RM; Fosdick L; Grandits GA; Lillemoe TJ; Wood JR; Grambsch P; Louis TA; Potter JD
Cancer Epidemiol Biomarkers Prev; 1997 Dec; 6(12):1011-9. PubMed ID: 9419396
[TBL] [Abstract][Full Text] [Related]
13. Flow cytometry and in vitro tritiated thymidine labeling in normal rectal mucosa of patients at high risk of colorectal cancer.
Paganelli GM; Lalli E; Facchini A; Biasco G; Santucci R; Brandi G; Barbara L
Am J Gastroenterol; 1994 Feb; 89(2):220-4. PubMed ID: 8304307
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of a new 3.3 g b.i.d. tablet formulation in patients with mild-to-moderately-active ulcerative colitis: a multicenter, randomized, double-blind, placebo-controlled study.
Scherl EJ; Pruitt R; Gordon GL; Lamet M; Shaw A; Huang S; Mareya S; Forbes WP
Am J Gastroenterol; 2009 Jun; 104(6):1452-9. PubMed ID: 19491859
[TBL] [Abstract][Full Text] [Related]
15. Chemoprevention of colorectal cancer in inflammatory bowel disease? A potential role for folate.
Mouzas IA; Papavassiliou E; Koutroubakis I
Ital J Gastroenterol Hepatol; 1998 Aug; 30(4):421-5. PubMed ID: 9789142
[TBL] [Abstract][Full Text] [Related]
16. Effect of a probiotic preparation (VSL#3) on induction and maintenance of remission in children with ulcerative colitis.
Miele E; Pascarella F; Giannetti E; Quaglietta L; Baldassano RN; Staiano A
Am J Gastroenterol; 2009 Feb; 104(2):437-43. PubMed ID: 19174792
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of DNA methyltransferase-1 in non-neoplastic epithelium helps predict colorectal neoplasia risk in ulcerative colitis.
Fujii S; Katake Y; Tanaka H
Digestion; 2010; 82(3):179-86. PubMed ID: 20588031
[TBL] [Abstract][Full Text] [Related]
18. Confocal endomicroscopy in patients with ulcerative colitis.
Watanabe O; Ando T; Maeda O; Hasegawa M; Ishikawa D; Ishiguro K; Ohmiya N; Niwa Y; Goto H
J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S286-90. PubMed ID: 19120913
[TBL] [Abstract][Full Text] [Related]
19. Surgery for neoplastic changes in ulcerative colitis--can limited resection be justified? Outcome for patients who underwent limited surgery.
Lindberg J; Stenling R; Palmqvist R; Rutegård J
Colorectal Dis; 2006 Sep; 8(7):551-6. PubMed ID: 16919105
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis and the risk of developing malignancies. A large prospective study.
Terg R; Sambuelli A; Coronel E; Mazzuco J; Cartier M; Negreira S; Muñoz A; Gil A; Miguez C; Huernos S; Romero G; Goncalvez S; Levi D; Abecasis R
Acta Gastroenterol Latinoam; 2008 Mar; 38(1):26-33. PubMed ID: 18533354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
